Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BCRX

Biocryst Pharmaceuticals Inc

Jun 01 • 04:00PM ET

8.57

-0.34 -3.82 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: ALKS INDV NBIX MIRM PTCT RYTM BMRN INCY KRYS HCM

| Held by: VTI XBI IWM VB VXF IBB VBK IWO CALF VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	15.23%	Shs Outstand	254.01M	Perf Week	3.38%
Market Cap	2.18B	Forward P/E	27.35	EPS next Y	0.31	Insider Trans	-1.22%	Shs Float	215.45M	Perf Month	-6.44%
Enterprise Value	2.80B	PEG	-	EPS next Q	0.16	Inst Own	84.53%	Short Float	16.76%	Perf Quarter	-0.70%
Income	-457.98M	P/S	2.46	EPS this Y	-321.28%	Inst Trans	16.24%	Short Ratio	6.73	Perf Half Y	20.70%
Sales	885.72M	P/B	-	EPS next Y	111.70%	ROA	-96.92%	Short Interest	36.11M	Perf YTD	9.87%
Book/sh	-2.18	P/C	9.10	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -24.23%	Perf Year	-20.28%
Cash/sh	0.94	P/FCF	7.43	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 42.83%	Perf 3Y	2.15%
Dividend Est.	-	EV/EBITDA	8.79	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	4.87% 5.10%	Perf 5Y	-46.27%
Dividend TTM	-	EV/Sales	3.16	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.42	Perf 10Y	148.41%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	44.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	-3.41%	Beta	0.56	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-6.38%	Rel Volume	0.55	Prev Close	8.91
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	8.15%	Avg Volume	5.36M	Price	8.57
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	2,923,117	Change	-3.82%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)